𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C – a critical review

✍ Scribed by Arne Schäfer; Hans-Ulrich Wittchen; Jochen Seufert; Michael R. Kraus


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
300 KB
Volume
16
Category
Article
ISSN
1049-8931

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

In recent years, research on interferon (IFN)‐induced depressive symptoms in antivirally treated patients suffering from chronic hepatitis C (CHC) has considerably intensified. Profound scientific knowledge of this complication is of great relevance with regard to adherence, compliance, and premature therapy discontinuation.

Presently, there is considerable variability of both, the frequency and extent of IFN‐induced depression reported in different cohorts of patients.

The aim of the presented study was to systematically review recent literature of research within this field; and particularly (1) to identify to what extent methodological bias contributed to inconsistent results in different studies, (2) to critically appraise methods and results of studies published so far, and (3) to suggest directions for future work, especially with respect to alternative and improved methodological approaches.

The results of this critical review suggest that the variability of findings seem to be largely due to different study populations, treatment regimens, methodological approaches, and sometimes arbitrary or at least poorly defined choice of screening instruments for depression, particularly criteria for clinically relevant depression (cut‐off criteria).

Study designs and methodological approaches to investigate IFN‐alfa‐induced depression in patients with CHC have been incoherent. Future research in this field needs agreement on the use of standardized assessment of IFN‐induced depression in CHC. Furthermore, objective criteria and guidelines for the treatment of IFN‐induced depression in these patients are needed in clinical practice. Copyright © 2008 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Serum levels of hepatitis C virus core p
✍ E Tanaka; K Kiyosawa; A Matsumoto; T Kashiwakuma; A Hasegawa; H Mori; O Yanagiha 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

The quantitation of hepatitis C virus (HCV) viremia RNA is measured by molecular techniques such as comcan be helpful in the diagnosis, therapy, and monitoring petitive reverse-transcription polymerase chain reacof patients with chronic hepatitis C. A sensitive and tion and branched DNA (bDNA) signa

A pilot study of corticosteroid priming
✍ K Chayama; A Tsubota; M Kobayashi; M Hashimoto; Y Miyano; H Koike; M Kobayashi; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

These factors are important, because they may influpolymerase chain reaction. ence the outcome of treatment. Furthermore, the study From the Department of Gastroenterology, Toranomon Hospital, Okinaka did not evaluate the effect of treatment on HCV clear-Memorial Institute for Medical Research, Tor

Response to higher doses of interferon a
✍ K L Lindsay; G L Davis; E R Schiff; H C Bodenheimer; L A Balart; J L Dienstag; R 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

JANICE ALBRECHT, 12 AND THE HEPATITIS INTERVENTIONAL THERAPY GROUP\* with continued therapy at that dose; however, a propor-To evaluate response rates to 3, 5, or 10 million units tion of patients who do not respond to 12 weeks of treat-(MU) of interferon alfa-2b, given thrice weekly, and to ment wi